Montelukast does not increase the risk of attention-deficit/hyperactivity disorder in pediatric asthma patients: A nationwide population-based matched cohort study
Open Access
- 4 November 2020
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (6), 1369-1376
- https://doi.org/10.1016/j.jfma.2020.10.018
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial Hospital (CFRPG8J0131)
This publication has 23 references indexed in Scilit:
- Impact of asthma medication and familial factors on the association between childhood asthma and attention‐deficit/hyperactivity disorder: a combined twin‐ and register‐based studyClinical and Experimental Allergy, 2015
- Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case‐control studyPharmacoepidemiology and Drug Safety, 2015
- Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011International Journal of Clinical Pharmacy, 2014
- Montelukast-Induced Adverse Drug Reactions: A Review of Case Reports in the LiteraturePharmacology, 2014
- Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patientsKidney International, 2013
- Neonatal jaundice is a risk factor for childhood asthma: a retrospective cohort studyPediatric Allergy and Immunology, 2012
- Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: A nationwide, population-based studyJournal of Microbiology, Immunology and Infection, 2012
- Common behavioral problems among children wıth asthma: Is there a role of asthma treatment?Annals of Allergy, Asthma & Immunology, 2011
- Reports of suicidality in clinical trials of montelukastJournal of Allergy and Clinical Immunology, 2009
- Montelukast and psychiatric disorders in childrenPharmacoepidemiology and Drug Safety, 2009